|
|
||||||||
Copenhagen Muscle Research Centre, Department of Human Physiology, Institute of Exercise and Sports Sciences, University of Copenhagen, Copenhagen 2100, Denmark
| |
ABSTRACT |
|---|
|
|
|---|
After a single
bout of exercise, insulin action is increased in the muscles that were
active during exercise. The increased insulin action has been shown to
involve glucose transport, glycogen synthesis, and glycogen synthase
(GS) activation as well as amino acid transport. A major mechanism
involved in increased insulin stimulation of glucose uptake after
exercise seems to be the exercise-associated decrease in muscle
glycogen content. Muscle glycogen content also plays a pivotal role for
the activity of GS and for the ability of insulin to increase GS
activity. Insulin signaling in human skeletal muscle is activated by
physiological insulin concentrations, but the increase in insulin
action after exercise does not seem to be related to increased
insulin signaling [insulin receptor tyrosine kinase activity,
insulin receptor substrate-1 (IRS-1) tyrosine phosphorylation (RS1),
IRS-1-associated phosphatidylinositol 3-kinase activity, Akt
phosphorylation (Ser473), glycogen synthase kinase 3 (GSK3)
phosphorylation (Ser21), and GSK3
activity], as
measured in muscle lysates. Furthermore, insulin signaling is also
largely unaffected by exercise itself. This, however, does not preclude
that exercise influences insulin signaling through changes in the
spatial arrangement of the signaling compounds or by affecting
unidentified signaling intermediates. Finally, 5'-AMP-activated protein
kinase has recently entered the stage as a promising player in
explaining at least a part of the mechanism by which exercise enhances
insulin action.
glycogen synthase; muscle glucose transport; insulin sensitivity; glycogen
| |
INTRODUCTION |
|---|
|
|
|---|
A SINGLE BOUT OF EXERCISE results in an increase in the metabolic action of insulin. Yet, despite intense research in many laboratories, the molecular mechanism behind this phenomenon remains largely unexplained. Intuitively, one might expect that the insulin-signaling cascade is more sensitive toward activation in the postexercise period, hand in hand with the increased metabolic action of insulin. However, as will be discussed, this simple hypothesis has so far not been very fertile. In the present review, we will discuss the possible mechanisms behind the increased metabolic effect of insulin in the period after a single bout of exercise. This has been studied mainly from the perspective of insulin action on glucose transport and to a somewhat lesser extent on glycogen synthase (GS) activity, whereas other metabolic roles of insulin such as stimulation of amino acid transport and protein synthesis have been studied remarkably little.
To discuss the effect of exercise on insulin action satisfactorily, it is necessary to briefly discuss the isolated effect of insulin and exercise on the two most studied physiological end points of insulin action: glucose transport and GS activity.
| |
EFFECTS OF INSULIN ON MUSCLE GLUCOSE TRANSPORT AND GS ACTIVITY |
|---|
|
|
|---|
Insulin facilitates muscle glycogen synthesis through its action on both glucose transport and on GS activity. Insulin stimulates translocation of glucose transporter proteins (GLUT-4) to the plasma membrane, thereby enhancing the glucose transport capacity (66). This has been shown in in vitro-incubated human muscle strips, with the photolabeling technique, and in vivo after meal- and clamp-induced hyperinsulinemia with subcellular fractionation techniques (25, 42, 70). The cellular signals utilized to stimulate the translocation of the GLUT-4-containing vesicles and the vesicular docking apparatus likely involve activation of phosphatidylinositol 3-kinase (PI3K), Akt, and protein kinase C at a proximal and possibly phospholipase D at a further distal step of the insulin-signaling pathway (19, 39, 66). The synthesis of glycogen from endogenous glucose is under tight control by GS. GS activity is regulated both allosterically by glucose 6-phosphate and covalently by multisite phosphorylation. Insulin enhances the activity of GS by decreasing phosphorylation of the enzyme (12). The classical PI3K cascade also seems to be involved in the regulation of GS, possibly through deactivation of glycogen synthase kinase 3 (GSK3) and activation of protein phosphatase-1 (PP1) (8, 41, 84). In human muscle, physiological hyperinsulinemia leads to time-dependent activation of the PI3K cascade, including deactivation of GSK3, which precedes the activation time course of both GS and glucose uptake (79, 80). Although these findings do not prove a causal link between the signal and the end point, they do support and extend the massive amount of data from studies performed in cell cultures and rodents, which suggest such links (reviewed in Refs. 20 and 66).
| |
EFFECTS OF EXERCISE/CONTRACTION ON MUSCLE GLUCOSE TRANSPORT AND GS ACTIVITY |
|---|
|
|
|---|
The factors thought to be involved in exercise-induced glucose transport have recently been reviewed (58). However, the regulation of glycogen synthesis and GS activity during exercise has received less attention; some detail of this matter is given here. During exercise, human skeletal muscle relies strongly on intramuscular glycogen stores as a source of energy for contractile activity. To facilitate net glycogen breakdown, one could expect that glycogen synthesis was shut down. However, experiments with NMR spectroscopy have shown that the rate of glycogen synthesis after glycogen depletion is actually higher during low-intensity exercise than at rest (54, 55) (reviewed in Ref. 65). This is probably because GS activity is also increased during dynamic exercise, which lowers the muscle glycogen content (4, 87).
GS is influenced by both stimulatory and inhibitory factors during
exercise, and the consequent effect of exercise on GS activity is a
result of the relative strength of the various stimuli. Several human
studies have shown that muscle GS activity is higher in a
glycogen-depleted state compared with a glycogen-loaded state (7,
46, 79, 86, 89), and it has been suggested that exercise-induced
GS activation is dependent on, and merely a result of, glycogen
breakdown (48). The mechanism behind this dependency is
unknown but at least in rodents seems to involve both covalent modifications of GS, as the apparent molecular mass of GS increases (83), and changes in the subcellular localization of GS
(48). Whether these two changes are linked is unknown, but
cellular redistribution of GS induced by glycogen depletion
(48) could for instance make GS more susceptible to
dephosphorylation. Conversely, the covalent modifications of GS, seen
during conditions with high muscle glycogen content, are only partly
reversible by phosphatase treatment (83), indicating the
involvement of phosphorylation-dependent regulatory mechanisms in
addition to other unknown factors. An important role of phosphatases in
exercise-induced activation of GS is suggested by recent work in
transgenic mice showing that the PP1 (GS phosphatase) targeting subunit
GM (RGl) is required for exercise to activate
GS (1), although the mechanism by which exercise affects
GM is not clarified. In support of the notion that glycogen
breakdown is a prerequisite for activation of GS, dynamic exercise that
leads to GS activation in healthy subjects actually decreased GS
activity in patients with McArdle's disease, who are unable to break
down muscle glycogen due to inborn glycogen phosphorylase deficiency
(49a). It is also noteworthy that isometric exercise
decreases GS activity (31, 34). This has been ascribed to
decreased PP1 activity (31, 34), but increased activity of
protein kinase A has also been suggested to inhibit GS, at least during
dynamic exercise (86). Isometric exercise is likely to be
associated with some degree of hypoxia, and both hypoxia and exercise
activate the 5'-AMP-activated protein kinase (AMPK) (reviewed in Refs.
28 and 77). Interestingly, AMPK has been shown to
phosphorylate GS in vitro (9), and pharmacological AMPK
activation decreases GS activity in rodent muscle (83). Thus activation of AMPK during exercise might work as an endogenously activated GS kinase. Another kinase known to phosphorylate and deactivate GS is GSK3. GSK3
has been suggested to take part in the
regulation of GS activity during exercise in rats (43). However, in humans, GSK3
activity is unchanged by exercise and unaffected by marked differences in muscle glycogen content (Ref. 85 and J. F. P. Wojtaszewski, C. MacDonald,
J. N. Nielsen, Y. Hellsten, D. G. Hardie, B. E. Kemp, B. Kiens, and E. A. Richter, unpublished observations). Therefore,
GSK3
does not seem to be involved in GS regulation during moderate
exercise in humans.
| |
INSULIN ACTION AND INSULIN SIGNALING DURING EXERCISE |
|---|
|
|
|---|
Ordinarily, the insulin concentrations in plasma decrease during exercise (22); relatively little attention has been given to the possible effects of the low circulating insulin concentrations during postabsorptive exercise. Nevertheless, in severely insulin-deficient animals, exercise-induced glucose uptake is decreased compared with when basal insulin concentrations are present (73), even when exaggerated hormonal and substrate responses to the very low insulin concentrations are avoided (75). In vitro, it has been convincingly demonstrated that muscle glucose uptake during contractions occurs by an insulin-independent mechanism (47, 52, 62, 74) and that insulin and contraction have additive effects on glucose transport (47, 53). Taken together with the in vivo findings, these in vitro findings suggest that, although insulin is not necessary for muscle contraction to increase muscle glucose transport, at least in vivo the full effect of exercise on muscle glucose uptake is only found when basal plasma insulin concentrations are present. In addition, in vivo, the effect of exercise and euglycemic hyperinsulinemia is synergistic (13), which could be interpreted as an increase in insulin sensitivity during exercise. However, whether insulin sensitivity in its strict sense (decreased half-maximally stimulating insulin concentration) is increased is not known because a full dose-response curve of insulin action on glucose uptake at rest and during exercise has not been performed in humans.
During exercise, the perfusion of the muscle is dramatically increased compared with at rest; in this way, the delivery of insulin (plasma flow × plasma insulin concentration) is markedly enhanced during exercise even when plasma insulin concentrations are reduced by up to 50% during exercise. It has been suggested that this increase in delivery of insulin during exercise is the reason for the apparent marked effect of basal insulin concentrations during exercise compared with when insulin is virtually absent (73, 75). Still, if this were the case, one might expect insulin signaling to be upregulated during exercise compared with at rest. In rodents, this is apparently not the case, at least for the most proximal parts of the insulin-signaling cascade. Thus treadmill running did not increase insulin receptor and insulin receptor substrate 1/2 (IRS-1/2) tyrosine phosphorylation, total and IRS-1/2-associated PI3K activity, Akt activity, and GSK3 serine phosphorylation in rodent muscle (30, 82, 90). This is in agreement with studies of the intact rat, the perfused hindlimb rat model, and the incubated rat muscle preparation in which electrically stimulated muscle showed no activation or deactivation of proximal insulin signaling elements (24, 67, 76, 81, 88). Only few human studies have been done, and the results are less consistent. Thus moderate exercise has been found to induce a modest phosphorylation of Akt, whereas in another study tyrosine phosphorylation of the insulin receptor was decreased and IRS-1 tyrosine phosphorylation and IRS-1-associated PI3K activity were unchanged (38, 70).
| |
INSULIN ACTION AND SIGNALING IN THE POSTEXERCISE PERIOD |
|---|
|
|
|---|
Low muscle glycogen availability limits the ability to perform exercise (5). Resynthesis of muscle glycogen after exercise is therefore important. However, if no carbohydrate is ingested after exercise, glycogen stores are only rebuilt slowly and incompletely. This is because the process of glucose uptake rapidly normalizes after exercise mainly due to a decline in glucose delivery (muscle perfusion) and a decline in glucose transport capacity of the cell surface membrane (reviewed in Ref. 57). On the other hand, mechanisms exist to secure a high rate of glycogen storage once carbohydrate becomes available, and these mechanisms are so efficient that glycogen levels can be rebuilt to levels higher than the normal resting level (supercompensation). The phenomenon primarily involves an enhancement of the metabolic action of insulin in the previously exercised muscles (previously reviewed in Refs. 29 and 78). It should be noted that exercise does not always increase insulin action. For example, immediately after exercise, insulin action in vivo is impaired possibly due to elevated concentrations of catecholamines and free fatty acids (17, 36, 37). Likewise, eccentric exercise or physical activities with a dominant component of eccentric contractions elicit a prolonged decrease in insulin action, which may be caused by altered protein expression and function (2, 3, 14, 71).
Studies in humans during hyperinsulinemic euglycemic clamp conditions
revealed improved insulin sensitivity of glucose clearance at the whole
body level in the period after a single bout of cycle or stair-climbing
exercise (7, 18, 45, 51). These changes have been observed
as long as 2 days after the exercise bout (45, 51).
Skeletal muscle is normally the major tissue targeted by insulin, and
changes in this tissue are likely the predominant causes of the effect
seen at the whole body level. Improved insulin action is primarily seen
in the previously active rather than the inactive muscles. For example,
in postabsorptive healthy subjects, glucose uptake across the rested
and exercised leg was similar when measured 3 h after one-legged
exercise. However, insulin's ability to stimulate glucose uptake at
this point was twofold higher in the exercised leg compared with the
rested leg (61). In that study, insulin action was
elevated both at submaximal and maximal effective insulin
concentrations; however, a clear shift of the dose-response curve to
the left was still evident, indicating an increased insulin sensitivity
of muscle glucose uptake (Fig. 1)
(61).
|
What is the mechanism behind the enhanced metabolic effect of insulin
(Fig. 2)? At early time points (3-4
h) after exercise, during which insulin sensitivity is increased,
protein expression of GLUT-4 and insulin signaling intermediaries and
total activity of GS are not elevated in human muscle
(79). At later time points, enhanced protein expression of
GLUT-4 is much more likely to have occurred and, although not yet
reported in humans, apparently may be an important mechanism in
increasing insulin action in rodents (56). Still, in
isolated muscle, in which protein synthesis is inhibited by incubation
with cycloheximide, muscle contraction leads to a normal increase in
insulin sensitivity (21). This indicates that protein
synthesis-independent mechanisms may also improve insulin sensitivity.
The classical PI3K signaling cascade proposed to activate some
metabolic events in skeletal muscle, including glucose transport and GS
activity, has been studied in humans during hyperinsulinemic clamps
conditions 3-4 h after one-legged knee extensor exercise
(79, 80). With the use of this model, only a small muscle
group performed work, and systemic changes induced by exercise were
minimal and not present at the time when the clamp was initiated. In
whole muscle lysates, activity or degrees of phosphorylation of the
insulin receptor, IRS-1, IRS-1-associated PI3K, Akt, and GSK3 were
determined. In neither step of the cascade was the level of
steady-state activation/phosphorylation enhanced in the exercised
compared with the resting muscle. Thus, in muscle lysates, no changes
were observed that could explain the enhanced GS activation or the
enhanced glucose uptake in the exercised muscle. Similar observations
have been observed in rodent muscle stimulated in vivo with
supramaximal or in vitro with submaximal effective insulin
concentrations (24, 27). Thus, despite measurable changes
in signals to glucose transport and GS in total muscle lysates from
rested muscle, it was not possible to pick up enhanced signals in
exercised muscles despite a markedly enhanced effect on glucose
transport and GS activity. Similarly, when the metabolic action of
insulin is decreased for example by prior caffeine ingestion (69) or in relatives to patients with Type 2 diabetes
(68), signals induced by physiological concentrations of
insulin were also unchanged. Thus, in a range of conditions with
changed metabolic action of insulin, it has not been possible to point
out signaling alterations in total muscle lysates.
|
There are several possible reasons for this negative outcome. The first is that there is not necessarily a linear relationship between insulin signaling and insulin action. The second possibility might be that the assays used to measure signaling simply are not sensitive enough to pick up possibly small but significant changes in signaling. Third, signaling today is measured in muscle lysates. It might be that the subcellular localization of the signaling intermediaries is important for action, and this is completely missed by homogenizing the muscle before analysis. Finally, an obvious possibility is that the important signaling related to exercise-induced increased insulin sensitivity is downstream of the Akt/GSK3 step, which is as far down as the signaling cascade presently is revealed.
Recent human (11) and rodent (72) data suggest that insulin in rested muscle may increase microvascular blood volume (capillary recruitment) even in the absences of changes in total blood flow. Thus it is likely that improved delivery and distribution of both insulin and glucose may enhance insulin action on muscle glucose uptake in vivo. Especially after exercise, improved insulin-mediated capillary perfusion might be of importance for increased insulin sensitivity and could potentially explain the faster activation of glucose transport and of GS in the exercised compared with the rested leg (79, 80). If so, one might also expect a faster activation of the insulin signaling cascade, which, however, was not a general finding (79, 80). Therefore, the effect of previous exercise on capillary perfusion during insulin stimulation awaits direct experimental evidence. Evidence for a blood flow-independent effect of exercise on insulin action is the observation that insulin action on glucose uptake and transport is also increased after contraction in perfused rat muscles (59) in the absence of increased muscle perfusion (62) as well as in the isolated and incubated muscle preparation (23). Thus cellular changes in the exercised muscles seem to prime the glucose transport system and GS for activation when subsequently stimulated by insulin. In incubated muscle isolated from swim-exercised rats, enhanced insulin-stimulated recruitment of glucose transporter proteins (GLUT-4) to the plasma membrane was evident; this seems to be the major mechanism responsible for the enhanced insulin-stimulated glucose transport after exercise (27).
Nonoxidative glucose metabolism is the predominant pathway by which exercised muscles handle the increased amount of glucose taken up (7, 45, 51). This is due to at least two different mechanisms increasing GS activity. The first is increased insulin-induced activation of GS after exercise, which has been observed in both rodents and humans (59, 79). The second is increased GS activity because of glycogen depletion, as discussed above in EFFECTS OF EXERCISE/CONTRACTION ON MUSCLE GLUCOSE TRANSPORT AND GS ACTIVITY. The interesting thing about GS activation and exercise is that GS activity is tightly coupled to glycogen concentration (48) and therefore is increased after exercise for as long as it takes to replenish muscle glycogen. In this respect, the response is much different from the response of glucose transport, which always decreases rapidly and markedly (but not necessarily completely) after exercise, even in the absence of glycogen repletion (reviewed Ref. 57).
It has long been known that exercise-induced changes in insulin sensitivity of muscle glucose transport determined in vitro are linked to carbohydrate availability in the period after exercise. Thus, in rodent muscle, carbohydrate deprivation after exercise extends the period of improved insulin sensitivity (10, 26). In humans, intake of 100 g of glucose 3 h after cycle exercise eliminated the increase in whole body insulin action 12 h later (7). In this context, it is noteworthy that in both human and rodent muscle insulin's ability to activate the glucose transport process is enhanced when glycogen storage is decreased. For example, in rodents, glycogen levels have been manipulated by exercise and diet in the days up to the experiment. In both perfused and incubated muscles, enhanced stimulatory effects of insulin on glucose transport/GLUT-4 recruitment were found when glycogen levels were decreased below normal, whereas decreased insulin action was observed when glycogen was supercompensated (16, 32, 33). When glycogen content is decreased in human muscle by dynamic knee extensions and insulin action subsequently is evaluated by the hyperinsulinemic euglycemic clamp technique, the increase in glucose uptake is correlated to the amount of glycogen used during the exercise bout (58). Furthermore, muscle glycogen content also affects the insulin-induced GS activity and rate of glycogen synthesis. Thus an inverse relationship between GS activation and muscle glycogen content exists during euglycemic hyperinsulinemia when studied 15 h after glycogen-depleting exercise or a similar period of rest (7). In addition, glycogen-dependent insulin-induced GS activation has been observed in humans after exercise when the endogenous insulin concentration was elevated in response to a meal (85). However, from these studies, it is difficult to distinguish between the role of glycogen and the role of enhanced insulin sensitivity induced by the prior exercise itself. Nevertheless, decreasing muscle glycogen concentrations by incubation with epinephrine also increases subsequent insulin sensitivity (50), supporting a role of glycogen of its own in regulation of insulin sensitivity. Patients with muscle glycogen phosphorylase deficiency (McArdle's disease) have muscle glycogen levels in the basal state that are approximately twofold higher than those in healthy matched control subjects. Thus these patients offer the possibility to elucidate the role of high-glycogen concentrations without the confounding influence of prior exercise and diet manipulation. In the McArdle patients, the basal activity of GS was low; however, more importantly, the increase in whole body glucose clearance and GS activity in response to stimulation by a physiological insulin concentration was impaired (49). When the difference in muscle glycogen level between McArdle patients and control subjects was correlated to the difference in insulin-induced increase in GS activity between McArdle patients and control subjects, the high glycogen levels in these patients could to a great extent explain the impaired increase in insulin-induced GS activity (r2 = 0.91, P = 0.002). In concordance, it has also been reported in healthy humans that insulin-stimulated glycogen synthesis measured by 31P-NMR spectroscopy was reduced in a glycogen-loaded condition (40). The reduction was not due to increased turnover of glycogen, pointing to an impaired action of GS. Thus a range of experimental evidence suggests that "simply" lowering muscle glycogen will enhance insulin's activation of glucose transport, GS activity, and glycogen synthesis, whereas increasing glycogen concentrations will result in opposite changes.
The molecular mechanisms utilized by glycogen to influence the action of insulin are not known, but two observations suggest that changes in insulin signaling levels could be involved. In rodent muscle with lowered glycogen content, Akt is activated by insulin to a greater extent than in muscle with normal glycogen levels (15, 33). Likewise, rodent and human muscles with low glycogen content have higher basal AMPK activity (unpublished observations and Refs. 33, 60, 83). Because prior 5-aminoimidazole-4-carboxamide riboside (AICAR, a pharmacological AMPK activator) treatment leads to enhanced insulin sensitivity of glucose transport in incubated rodent muscle (21), it may be that glycogen-dependent insulin action is mediated by AMPK. Whether glycogen-induced alterations in signaling levels of Akt and AMPK are linked is unknown.
Other stimuli of glucose transport such as hypoxia, which like exercise enhances glycogenolysis, also lead to subsequent enhancement of insulin sensitivity, at least in rodent muscle (21). Nevertheless, some evidence suggests that glycogen breakdown is not necessary for enhancement of insulin action in muscle. For example, as mentioned above, AICAR treatment of incubated muscle results in enhanced insulin sensitivity of glucose transport without any measurable changes in glycogen content (21). In addition, after exercise, the increase in insulin sensitivity seems to persist beyond the point of glycogen normalization in both human (6) and rodent muscle (59). Therefore, evidence suggests that glycogen breakdown is a major but not the only contributor to enhancement of insulin sensitivity.
| |
PERSPECTIVES |
|---|
|
|
|---|
The effect of prior exercise to enhance insulin action has been well documented for 20 years and has been known as a clinical fact by diabetologists for much longer. Nevertheless, despite intense research efforts, the observation still stands fairly unexplained in terms of the molecular mechanisms involved. It is clear that the lowered glycogen content of the muscle after exercise plays a pivotal role in determining the insulin response of glucose transport and glycogen synthesis, but how this is brought about in molecular terms remains elusive. Rather disappointingly, the prevailing finding has been that postexercise-increased insulin action in muscle is not related to increased insulin signaling, as studied today in muscle lysates. Perhaps we need to look more at the spatial arrangements of the signaling molecules in the muscle cell and study whether this might be changed by exercise in a way that makes signaling more effective. Changes in insulin signaling that are important for insulin sensitivity could also lie beyond the Akt/GSK3 steps. Alternatively, because exercise, by depletion of glycogen stores, creates a state of fuel deficit in the muscle, incoming glucose is diverted to glycogenesis and incoming fatty acids primarily to oxidation (35). In this way, the conditions are quite opposite to those of lipid oversupply, recently suggested to cause insulin resistance (44, 63, 64), and therefore might in fact result in increased insulin sensitivity. Finally, activation of AMPK with AICAR also causes increased insulin sensitivity without glycogen depletion (21), and this observation suggests that targets downstream of AMPK may be involved in determining insulin sensitivity, which is another venue to explore.
| |
ACKNOWLEDGEMENTS |
|---|
J. F. P. Wojtaszewski was supported by a postdoctoral fellowship from the Danish Medical Research Council. The study was supported by Grant 504-14 from the Danish National Research Foundation, by the Novo-Nordisk Research Foundation, and by a Research & Technological Development Project (QLG1-CT-2001-01488) funded by the European Commission.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: E. A. Richter, Copenhagen Muscle Research Centre, Dept. of Human Physiology, Institute of Exercise and Sports Sciences, Univ. of Copenhagen, 13 Universitetsparken, Copenhagen 2100, Denmark (E-mail: erichter{at}aki.ku.dk).
10.1152/japplphysiol.00043.2002
| |
REFERENCES |
|---|
|
|
|---|
1.
Aschenbach, WG,
Suzyki Y,
Breeden K,
Prats C,
Hirshman MF,
Dufresne SD,
Sakamoto K,
Vilardo P,
Steele M,
Kim J,
Jing S,
Goodyear LJ,
and
DePaoli-Roach AA.
The muscle-specific protein phosphatase PP1G/R GL is essential for activation of glycogen synthase by exercise.
J Biol Chem
276:
39959-39967,
2001.
2.
Asp, S,
Daugaard JR,
Kristiansen S,
Kiens B,
and
Richter EA.
Eccentric exercise decreases maximal insulin action in humans: muscle and systemic effects.
J Physiol
494:
891-898,
1996.
3.
Asp, S,
Daugaard JR,
and
Richter EA.
Eccentric exercise decreases glucose transporter GLUT4 protein in human skeletal muscle.
J Physiol
482:
705-712,
1995.
4.
Bak, JF,
and
Perdersen O.
Exercise-enhanced activation of glycogen synthase in human skeletal muscle.
Am J Physiol Endocrinol Metab
258:
E957-E963,
1990.
5.
Bergström, J,
Hermansen L,
Hultman E,
and
Saltin B.
Diet, muscle glycogen and physical performance.
Acta Physiol Scand
71:
140-150,
1967.
6.
Bergström, J,
and
Hultman E.
Muscle glycogen synthesis after exercise: an enhancing factor localized to the muscle cells in man.
Nature
210:
309-310,
1966.
7.
Bogardus, C,
Thuillez P,
Ravussin E,
Vasquez B,
Narimiga M,
and
Azhar S.
Effect of muscle glycogen depletion on in vivo insulin action in man.
J Clin Invest
72:
1605-1610,
1983.
8.
Brady, MJ,
and
Saltiel AR.
The role of protein phosphatase-1 in insulin action.
Recent Prog Horm Res
56:
157-173,
2001.
9.
Carling, D,
and
Hardie DG.
The substrate and sequence specificity of the AMP-activated protein kinase. Phosphorylation of glycogen synthase and phosphorylase kinase.
Biochim Biophys Acta
1012:
81-86,
1989.
10.
Cartee, G,
Young D,
Sleeper M,
Zierath J,
Wallberg-Henriksson H,
and
Holloszy JO.
Prolonged increase in insulin-stimulated glucose transport in muscle after exercise.
Am J Physiol Endocrinol Metab
256:
E494-E499,
1989.
11.
Coggins, M,
Lindner J,
Rattigan S,
Jahn L,
Fasy E,
Kaul S,
and
Barret E.
Physiological hyperinsulinemia enhances human skeletal muscle perfusion by capillary recruitment.
Diabetes
50:
2682-2690,
2001.
12.
Cohen, P.
Dissection of the protein-phosphorylation cascades involved in insulin and growth factor action.
Biochem Soc Trans
21:
555-567,
1993.
13.
DeFronzo, RA,
Ferrannini E,
Sato Y,
Felig P,
and
Wahren J.
Synergistic interaction between exercise and insulin on peripheral glucose uptake.
J Clin Invest
68:
1468-1474,
1981.
14.
Del Aguila, LF,
Krishnan RK,
Ulbrecht JS,
Farrell PA,
Correll PH,
Lang CH,
Zierath JR,
and
Kirwan JP.
Muscle damage impairs insulin stimulation of IRS-1, PI 3-kinase, and Akt-kinase in human skeletal muscle.
Am J Physiol Endocrinol Metab
279:
E206-E212,
2000.
15.
Derave, W,
Hansen BF,
Lund S,
Kristiansen S,
and
Richter EA.
Muscle glycogen content affects insulin-stimulated glucose transport and protein kinase B activity.
Am J Physiol Endocrinol Metab
279:
E947-E955,
2000.
16.
Derave, W,
Lund S,
Holman GD,
Wojtaszewski JFP,
Pedersen O,
and
Richter EA.
Contraction-stimulated muscle glucose transport and GLUT-4 surface content are dependent on glycogen content.
Am J Physiol Endocrinol Metab
277:
E1103-E1110,
1999.
17.
Devlin, J,
Barlow J,
and
Horton E.
Whole body and regional fuel metabolism during early postexercise recovery.
Am J Physiol Endocrinol Metab
256:
E167-E172,
1989.
18.
Devlin, J,
Hirshman MF,
and
Horton E.
Enhanced peripheral and splanchnic insulin sensitivity in NIDDM men after single bout of exercise.
Diabetes
36:
434-439,
1987.
19.
Emoto, M,
Klarlund JK,
Waters SB,
Hu V,
Buxton JM,
Chawla A,
and
Czech MP.
A role for phospholipase D in GLUT4 glucose transporter translocation.
J Biol Chem
275:
7144-7151,
2000.
20.
Farese, RV.
Insulin sensitive phospholipid signaling systems and glucose transport. Update II.
Exp Biol Med
226:
283-295,
2001.
21.
Fisher, JS,
Gao J,
Han DH,
Holloszy JO,
and
Nolte LA.
Activation of AMP kinase enhances sensitivity of muscle glucose transport to insulin.
Am J Physiol Endocrinol Metab
282:
E18-E23,
2002.
22.
Galbo, H.
Hormonal and Metabolic Adaptations to Exercise. New York: Thieme, 1983, p. 1-116.
23.
Gao, J,
Gulve EA,
and
Holloszy JO.
Contraction-induced increase in muscle insulin sensitivity: requirement for a serum factor.
Am J Physiol Endocrinol Metab
266:
E186-E192,
1994.
24.
Goodyear, LJ,
Giorgino F,
Balon TW,
Condorelli G,
and
Smith RJ.
Effects of contractile activity on tyrosine phosphoproteins and PI 3-kinase in rat skeletal muscle.
Am J Physiol Endocrinol Metab
268:
E987-E995,
1995.
25.
Goodyear, LJ,
Hirshman MF,
Napoli R,
Calles J,
Markuns JF,
Ljungqvist O,
and
Horton ES.
Glucose ingestion causes GLUT4 translocation in human skeletal muscle.
Diabetes
45:
1051-1056,
1996.
26.
Gulve, EA,
Cartee GD,
Zierath JR,
Corpus VM,
and
Holloszy JO.
Reversal of enhanced muscle glucose transport after exercise: roles of insulin and glucose.
Am J Physiol Endocrinol Metab
259:
E685-E691,
1990.
27.
Hansen, PA,
Nolte LA,
Chen MM,
and
Holloszy JO.
Increased GLUT-4 translocation mediates enhanced insulin sensitivity of muscle glucose transport after exercise.
J Appl Physiol
85:
1218-1222,
1998.
28.
Hardie, DG,
and
Hawley SA.
AMP-activated protein kinase: the energy charge hypothesis revisited.
Bioessays
23:
1112-1119,
2001.
29.
Holloszy, JO,
Kohrt WM,
and
Hansen PA.
The regulation of carbohydrate and fat metabolism during and after exercise.
Front Biosci
3:
D1011-D1027,
1998.
30.
Howlett, KF,
Sakamoto K,
Hirshman MF,
Aschenback WG,
Dow M,
White MF,
and
Goodyear LJ.
Insulin signaling after exercise in insulin receptor substrate 2 deficient mice.
Diabetes
51:
479-483,
2002.
31.
Katz, A,
and
Raz I.
Rapid activation of glycogen synthase and protein phosphatase in human skeletal muscle after isometric contraction requires an intact circulation.
Pflügers Arch
431:
259-265,
1995.
32.
Kawanaka, K,
Han DH,
Nolte LA,
Hansen PA,
Nakatani A,
and
Holloszy JO.
Decreased insulin stimulated GLUT-4 translocation in glycogen-supercompensated muscles of exercised rats.
Am J Physiol Endocrinol Metab
276:
E907-E912,
1999.
33.
Kawanaka, K,
Nolte LA,
Han DH,
Hansen PA,
and
Holloszy JO.
Mechanisms underlying impaired GLUT-4 translocation in glycogen-supercompensated muscles of exercised rats.
Am J Physiol Endocrinol Metab
279:
E1311-E1318,
2000.
34.
Kida, Y,
Katz A,
Lee AD,
and
Mott DM.
Contraction mediated inactivation of glycogen synthase is accompanied by inactivation of glycogen synthase phosphatase in human skeletal muscle.
Biochem J
259:
901-904,
1989.
35.
Kiens, B,
and
Richter EA.
Utilization of skeletal muscle triacylglycerol during postexercise recovery in humans.
Am J Physiol Endocrinol Metab
275:
E332-E337,
1998.
36.
Kjær, M,
Farrell P,
Christensen N,
and
Galbo H.
Increased epinephrine response and inaccurate glucoregulation in exercising athletes.
J Appl Physiol
61:
1693-1700,
1986.
37.
Kjær, M,
Hollenbeck C,
Frey-Hewitt B,
Galbo H,
Haskell W,
and
Reaven G.
Glucoregulation and hormonal responses to maximal exercise in non-insulin-dependent diabetes.
J Appl Physiol
68:
2067-2074,
1990.
38.
Koval, JA,
Maezono K,
Patti ME,
Pendergrass M,
DeFronzo RA,
and
Mandarino LJ.
Effects of exercise and insulin on insulin signaling proteins in human skeletal muscle.
Med Sci Sports Exerc
31:
998-1004,
1999.
39.
Kristiansen, S,
Nielsen JN,
Bourgoin S,
Klip A,
Franco M,
and
Richter EA.
GLUT-4 translocation in skeletal muscle studied with a cell-free assay: involvement of phospholipase D.
Am J Physiol Endocrinol Metab
281:
E608-E618,
2001.
40.
Laurent, D,
Hundal RS,
Dresner A,
Price TB,
Vogel SM,
Petersen KF,
and
Shulman GI.
Mechanism of muscle glycogen autoregulation in humans.
Am J Physiol Endocrinol Metab
278:
E663-E668,
2000.
41.
Lawrence, JC,
and
Roach PJ.
New insights into the role and mechanism of glycogen synthase activation by insulin.
Diabetes
46:
541-547,
1997.
42.
Lund, S,
Holman GD,
Zierath JR,
Rincon J,
Nolte LA,
Clark AE,
Schmitz O,
Pedersen O,
and
Wallberg-Henriksson H.
Effect of insulin on GLUT4 cell surface content and turnover rate in human skeletal muscle as measured by the exofacial bis-mannose photolabeling technique.
Diabetes
46:
1965-1969,
1997.
43.
Markuns, JF,
Wojtaszewski JFP,
and
Goodyear LJ.
Insulin and exercise decrease glycogen synthase kinase-3 activity by different mechanisms in rat skeletal muscle.
J Biol Chem
274:
24896-24900,
1999.
44.
McGarry, JD.
Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes.
Diabetes
51:
7-18,
2002.
45.
Mikines, K,
Sonne B,
Farrell P,
Tronier B,
and
Galbo H.
Effect of physical exercise on sensitivity and responsiveness to insulin in humans.
Am J Physiol Endocrinol Metab
254:
E248-E259,
1988.
46.
Munger, R,
Temler E,
Jallut D,
Haesler E,
and
Felber JP.
Correlations of glycogen synthase and phosphorylase activities with glycogen concentration in human muscle biopsies. Evidence for a double-feedback mechanism regulating glycogen synthesis and breakdown.
Metabolism
42:
36-43,
1993.
47.
Nesher, R,
Karl I,
and
Kipnis D.
Dissociation of effects of insulin and contraction on glucose transport in rat epitrochlearis muscle.
Am J Physiol Cell Physiol
249:
C226-C232,
1985.
48.
Nielsen, JN,
Derave W,
Kristiansen S,
Ralston E,
Ploug T,
and
Richter EA.
Glycogen synthase localization and activity in rat skeletal muscle is strongly dependent on glycogen content.
J Physiol
531:
757-769,
2001.
49.
Nielsen, JN,
Vissing J,
Wojtaszewski JFP,
Haller RG,
Begum N,
and
Richter EA.
Decreased insulin action in skeletal muscle from patients with McArdle's disease.
Am J Physiol Endocrinol Metab
282:
E1267-E1275,
2002.
49a.
Nielsen JN, Wojtaszewski JFP, Haller RG, Hardie DG, Kemp BE, Richter
EA, and Vissing J. Role of 5'-AMP-activated protein kinase in
glycogen synthase activity and glucose utilization: insights from
patients with McArdle's disease. J Physiol (In press).
50.
Nolte, LA,
Gulve EA,
and
Holloszy JO.
Epinephrine-induced in vivo muscle glycogen depletion enhances insulin sensitivity of glucose transport.
J Appl Physiol
76:
2054-5058,
1994.
51.
Perseghin, G,
Price TB,
Petersen KF,
Roden M,
Cline GW,
Gerow K,
Rothman DL,
and
Shulman GI.
Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin resistant subjects.
N Engl J Med
335:
1357-1362,
1996.
52.
Ploug, T,
Galbo H,
and
Richter EA.
Increased muscle glucose uptake during contractions: no need for insulin.
Am J Physiol Endocrinol Metab
247:
E726-E731,
1984.
53.
Ploug, T,
Galbo H,
Vinten J,
Jørgensen M,
and
Richter EA.
Kinetics of glucose transport in rat muscle: effects of insulin and contractions.
Am J Physiol Endocrinol Metab
253:
E12-E20,
1987.
54.
Price, TB,
Rothman DL,
Avison MJ,
Buonamico P,
and
Shulman RG.
C-NMR measurements of muscle glycogen during low-intensity exercise.
J Appl Physiol
70:
1836-1844,
1991.
55.
Price, TB,
Taylor R,
Mason GF,
Rothman DL,
Shulman GI,
and
Shulman RG.
Turnover of human muscle glycogen with low intensity exercise.
Med Sci Sports Exerc
26:
983-991,
1994.
56.
Ren, JM,
Semenkovich CF,
Gulve EA,
Gao J,
and
Holloszy JO.
Exercise induces rapid increases in GLUT4 expression, glucose transport capacity, and insulin-stimulated glycogen storage in muscle.
J Biol Chem
269:
14396-14401,
1994.
57.
Richter, EA.
Glucose utilization.
In: Handbook of Physiology. Exercise: Regulation and Integration of Multiple Systems. Bethesda, MD: Am. Physiol. Soc, 1996, sect. 12, chapt. 20, p. 912-951.
58.
Richter, EA,
Derave W,
and
Wojtaszewski JFP
Glucose, exercise and insulin. Emerging concepts.
J Physiol
535:
313-322,
2001.
59.
Richter, EA,
Garetto LP,
Goodman MN,
and
Ruderman NB.
Muscle glucose metabolism following exercise in the rat.
J Clin Invest
69:
785-793,
1982.
60.
Richter, EA,
Macdonald C,
Kiens B,
Hardie DG,
and
Wojtaszewski JFP
Dissociation of 5'AMP-activated protein kinase activity and glucose clearance in human skeletal muscle during exercise (Abstract).
Diabetes
50 Suppl 2:
A62,
2001.
61.
Richter, EA,
Mikines KJ,
Galbo H,
and
Kiens B.
Effect of exercise on insulin action in human skeletal muscle.
J Appl Physiol
66:
876-885,
1989.
62.
Richter, EA,
Ploug T,
and
Galbo H.
Increased muscle glucose uptake after exercise: no need for insulin during exercise.
Diabetes
34:
1041-1048,
1985.
63.
Ruderman, NB,
Saha AK,
Vavvas D,
Kurowski T,
Laybutt DR,
Schmitz-Peiffer C,
Biden T,
and
Kraegen EW.
Malonyl CoA as a metabolic switch and a regulator of insulin sensitivity.
Adv Exp Med Biol
441:
263-270,
1998.
64.
Ruderman, NB,
Saha AK,
Vavvas D,
and
Witters LA.
Malonyl-CoA, fuel sensing, and insulin resistance.
Am J Physiol Endocrinol Metab
276:
E1-E18,
1999.
65.
Shulman, RG,
and
Rothman DL.
The "glycogen shunt" in exercising muscle: a role for glycogen in muscle energetics and fatigue.
Proc Natl Acad Sci USA
98:
457-461,
2001.
66.
Simpson, F,
Whitehead JP,
and
James DE.
GLUT4
at the cross roads between membrane trafficking and signal transduction.
Traffic
2:
2-11,
2001.
67.
Soos, MA,
Jensen J,
Brown RA,
O'Rahilly S,
Shepherd PR,
and
Whitehead JP.
Class II phosphoinositide 3 kinase is activated by insulin but not by contraction in skeletal muscle.
Arch Biochem Biophys
396:
244-248,
2002.
68.
Storgaard, H,
Song XM,
Jensen CB,
Madsbad S,
Björnholm M,
Vaag A,
and
Zierath JR.
Insulin signal transduction in skeletal muscle from glucose-intolerant relatives with type 2 diabetes.
Diabetes
50:
2770-2778,
2001.
69.
Thong, FSL,
Derave W,
Kiens B,
Graham TE,
Urso B,
Wojtaszewski JFP,
Hansen BF,
and
Richter EA.
Caffeine-induced impairment of insulin action but not insulin signaling in human skeletal muscle is reduced by exercise.
Diabetes
51:
583-590,
2002.
70.
Thorell, A,
Hirshman MF,
Nygren J,
Jorfeldt L,
Wojtaszewski JFP,
Dufresne SD,
Horton ED,
Ljungqvist O,
and
Goodyear LJ.
Exercise and insulin cause GLUT-4 translocation in human skeletal muscle.
Am J Physiol Endocrinol Metab
277:
E733-E741,
1999.
71.
Tuominen, JA,
Ebeling P,
Bourey R,
Koranyi L,
Lamminen A,
Rapola J,
Sane T,
Vuorinen-Markkola H,
and
Koivisto VA.
Postmarathon paradox: insulin resistance in the face of glycogen depletion.
Am J Physiol Endocrinol Metab
270:
E336-E343,
1996.
72.
Vincent, MA,
Dawson D,
Clark AD,
Lindner JR,
Rattigan S,
Clark MG,
and
Barrett EJ.
Skeletal muscle microvasular recruitment by physiological hyperinsulimia precedes increases in total blood flow.
Diabetes
51:
42-48,
2002.
73.
Vranic, M,
Kawamori R,
Pek S,
Kovacevic N,
and
Wrenshall GA.
The essentiality of insulin and the role of glucagon in regulating glucose utilization and production during strenuous exercise in dogs.
J Clin Invest
57:
245-255,
1976.
74.
Wallberg-Henriksson, H,
and
Holloszy JO.
Contractile activity increases glucose uptake by muscle in severely diabetic rats.
J Appl Physiol
57:
1045-1049,
1984.
75.
Wasserman, DH,
Mohr T,
Kelly P,
Lacy B,
and
Bracy D.
Impact of insulin deficiency on glucose fluxes and muscle glucose metabolism during exercise.
Diabetes
41:
1229-1238,
1992.
76.
Whitehead, JP,
Soos MA,
Aslesen R,
O'Rahilly S,
and
Jensen J.
Contraction inhibits insulin stimulated insulin receptor substrate 1/2 associated phosphoinositide 3 kinase activity, but not protein kinase B activation or glucose uptake in rat muscle.
Biochem J
349:
775-781,
2000.
77.
Winder, WW.
Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle.
J Appl Physiol
91:
1017-1028,
2002.
78.
Wojtaszewski, JFP,
and
Goodyear LJ.
Cellular effects of exercise to promote muscle insulin sensitivity.
Curr Opin Endocrinol Diab
6:
129-134,
1999.
79.
Wojtaszewski, JFP,
Hansen BF,
Gade J,
Kiens B,
Markuns JF,
Goodyear LJ,
and
Richter EA.
Insulin signaling and insulin sensitivity after exercise in human skeletal muscle.
Diabetes
49:
320-325,
2000.
80.
Wojtaszewski, JFP,
Hansen BF,
Kiens B,
and
Richter EA.
Insulin signaling in human skeletal muscle: time course and effect of exercise.
Diabetes
46:
1775-1781,
1997.
81.
Wojtaszewski, JFP,
Hansen BF,
Ursø B,
and
Richter EA.
Wortmannin inhibits both insulin- and contraction-stimulated glucose uptake and transport in rat skeletal muscle.
J Appl Physiol
81:
1501-1509,
1996.
82.
Wojtaszewski, JFP,
Higaki Y,
Hirshman MF,
Michael MD,
Dufresne SD,
Kahn CR,
and
Goodyear LJ.
Exercise modulates postreceptor insulin signaling and glucose transport in muscle-specific insulin receptor knockout mice.
J Clin Invest
104:
1257-1264,
1999.
83.
Wojtaszewski, JFP,
Jørgensen SB,
Hellsten Y,
Hardie DG,
and
Richter EA.
Glycogen dependent effects of AICAR on 5'AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle.
Diabetes
51:
284-292,
2002.
84.
Wojtaszewski, JFP,
Lynge J,
Jacobsen AB,
Goodyear LJ,
and
Richter EA.
Differential regulation of MAP kinase by contraction and insulin in skeletal muscle: metabolic implications.
Am J Physiol Endocrinol Metab
277:
E724-E732,
1999.
85.
Wojtaszewski, JFP,
Nielsen P,
Kiens B,
and
Richter EA.
Regulation of glycogen synthase kinase 3 in human skeletal muscle: effects of bicycle exercise and food intake.
Diabetes
50:
265-269,
2001.
86.
Yan, Z,
Spencer MK,
and
Katz A.
Effect of low glycogen on glycogen synthase in human muscle during and after exercise.
Acta Physiol Scand
145:
345-352,
1992.
87.
Yan, Z,
Spencer MK,
and
Katz A.
No effect of carbohydrate feeding on glycogen synthase in human muscle during exercise.
Clin Physiol
13:
265-270,
1993.
88.
Yeh, JI,
Gulve EA,
Rameh L,
and
Birnbaum MJ.
The effects of wortmannin on rat skeletal muscle.
J Biol Chem
270:
2107-2111,
1995.
89.
Zachwieja, JJ,
Costill DL,
Pascoe DD,
Robergs RA,
and
Fink WJ.
Influence of muscle glycogen depletion on the rate of resynthesis.
Med Sci Sports Exerc
23:
44-48,
1991.
90.
Zhou, Q,
and
Dohm GL.
Treadmill running increases phosphatidylinositol 3-kinase activity in rat skeletal muscle.
Biochem Biophys Res Commun
236:
647-650,
1997.
This article has been cited by other articles:
![]() |
J. P. Thyfault Setting the stage: possible mechanisms by which acute contraction restores insulin sensitivity in muscle Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1103 - R1110. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Pratt, R. J. Geor, L. L. Spriet, and L. J. McCutcheon Time course of insulin sensitivity and skeletal muscle glycogen synthase activity after a single bout of exercise in horses J Appl Physiol, September 1, 2007; 103(3): 1063 - 1069. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Frosig, M. P. Sajan, S. J. Maarbjerg, N. Brandt, C. Roepstorff, J. F. P. Wojtaszewski, B. Kiens, R. V. Farese, and E. A. Richter Exercise improves phosphatidylinositol-3,4,5-trisphosphate responsiveness of atypical protein kinase C and interacts with insulin signalling to peptide elongation in human skeletal muscle J. Physiol., August 1, 2007; 582(3): 1289 - 1301. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Ropelle, J. R. Pauli, P. O. Prada, C. T. de Souza, P. K. Picardi, M. C. Faria, D. E. Cintra, M. F. d. A. Fernandes, M. B. Flores, L. A. Velloso, et al. Reversal of diet-induced insulin resistance with a single bout of exercise in the rat: the role of PTP1B and IRS-1 serine phosphorylation J. Physiol., December 15, 2006; 577(3): 997 - 1007. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hamada, E. B. Arias, and G. D. Cartee Increased submaximal insulin-stimulated glucose uptake in mouse skeletal muscle after treadmill exercise J Appl Physiol, November 1, 2006; 101(5): 1368 - 1376. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. H. Mortensen, L. Frandsen, P. Schjerling, E. Nishimura, and N. Grunnet PGC-1{alpha} and PGC-1beta have both similar and distinct effects on myofiber switching toward an oxidative phenotype Am J Physiol Endocrinol Metab, October 1, 2006; 291(4): E807 - E816. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wilson, M. Hargreaves, and K. F. Howlett Exercise does not alter subcellular localization, but increases phosphorylation of insulin-signaling proteins in human skeletal muscle Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E341 - E346. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hayashi, S. Nagasaka, N. Takahashi, I. Kusaka, S. Ishibashi, S. Numao, D. J. Lee, Y. Taki, H. Ogata, K. Tokuyama, et al. A Single Bout of Exercise at Higher Intensity Enhances Glucose Effectiveness in Sedentary Men J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4035 - 4040. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Teran-Garcia, T. Rankinen, R. A. Koza, D. C. Rao, and C. Bouchard Endurance training-induced changes in insulin sensitivity and gene expression Am J Physiol Endocrinol Metab, June 1, 2005; 288(6): E1168 - E1178. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Xiang, J. Naik, and R. L. Hester Exercise-induced increase in skeletal muscle vasodilatory responses in obese Zucker rats Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2005; 288(4): R987 - R991. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Sigal, G. P. Kenny, D. H. Wasserman, and C. Castaneda-Sceppa Physical Activity/Exercise and Type 2 Diabetes Diabetes Care, October 1, 2004; 27(10): 2518 - 2539. [Full Text] [PDF] |
||||
![]() |
E. A. McIntyre, R. Halse, S. J. Yeaman, and M. Walker Cultured Muscle Cells from Insulin-Resistant Type 2 Diabetes Patients Have Impaired Insulin, but Normal 5-Amino-4-Imidazolecarboxamide Riboside-Stimulated, Glucose Uptake J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3440 - 3448. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ross Does Exercise Without Weight Loss Improve Insulin Sensitivity? Diabetes Care, March 1, 2003; 26(3): 944 - 945. [Full Text] [PDF] |
||||
![]() |
G. S. Olsen and B. F. Hansen AMP kinase activation ameliorates insulin resistance induced by free fatty acids in rat skeletal muscle Am J Physiol Endocrinol Metab, November 1, 2002; 283(5): E965 - E970. |